Erratum: ERRATUM: (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation (Int J Oncol (2015) 46 (1507-1515) DOI: 10.3892/ijo.2015.2869);(-)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1507-1515

  Wang, Jiangyan ^a   Xie, Yu'an ^a   Feng, Yan ^a   Zhang, Litu ^a   Huang, Xinping ^a   Shen, Xiaoyun ^a   Luo, Xiaoling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

( ) epigallocatechingallate; Apoptosis; B lymphoma; Caspase; Pathway

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; DEATH RECEPTOR; EPIGALLOCATECHIN GALLATE; FAS ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; CATECHIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC50; JEKO 1 CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL LINE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; DOSE RESPONSE; DRUG EFFECTS; GENETICS; LYMPHOMA, B-CELL; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYMPHOMA, B-CELL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84923089494     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2024.5683     Document Type: Erratum

References (43)

1. SAID JW: Aggressive B-cell lymphomas: How many categories do we need. Mod Pathol 26 (Suppl 1): S42-S56, 2013.
2. VOSE JM: Mantle Cell lymphoma: 2012 update on diagnosis, risk-stratifcation, and clinical management. Am J Hematol 87: 604-609, 2012.
3. BOSCH F, LÓPEZ-GUILLERMO A, CAMPO E, RIBERA JM, CONDE E, PIRIS MA, VALLESPÍ T, WOESSNER S and MONTSERRAT E: Mantle Cell lymphoma: Presenting features, response to therapy, and prognostic factors. Cancer 82: 567-575, 1998.
4. LI ZJ, YAO C, LIU SF, CHEN L, XI YM, ZHANG W and ZHANG GS: Cytotoxic effect of icaritin and its mechanisms in inducing apoptosis in human burkitt lymphoma Cell line. Biomed Res Int 2014: 391512, 2014.
5. CHANG JE and KAHL BS: Current status of targeted therapies for Mantle Cell lymphoma. Drugs 71: 2307-2326, 2011.
6. CHEN D, MILACIC V, CHEN MS, et al: Tea poly phenols, t hei r biological effects and potential molecular targets. Histol Histopathol 23: 487-496, 2008.
7. KHAN N, AFAQ F, SALEEM M, AHMAD N and MUKHTAR H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigal-locatechin-3-gallate. Cancer Res 66: 2500-2505, 2006.
8. ŁUCZAJ W, WASZKIEWICZ E, SKRZYDLEWSKA E and ROSZKOWSKA-JAKIMIEC W: Green tea protection against age-dependent ethanol-induced oxidative stress. J Toxicol Environ Health A 67: 595-606, 2004.
9. BETTS JW and WAREHAM DW: In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol 14: 172, 2014.
10. XU X, ZHOU XD and WU CD: The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrob Agents Chemother 55: 1229-1236, 2011.
11. KURIYAMA S, SHIMAZU T, OHMORI K, KIKUCHI N, NAKAYA N, NISHINO Y, TSUBONO Y and TSUJI I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. JAMA 296: 1255-1265, 2006.
12. SONG Y, MANSON JE, BURING JE, SESSO HD and LIU S: Associations of dietary favonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic infammation in women: A prospective study and cross-sectional analysis. J Am Coll Nutr 24: 376-384, 2005.
13. HU G, BIDEL S, JOUSILAHTI P, ANTIKAINEN R and TUOMILEHTO J: Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 22: 2242-2248, 2007.
14. MOSELEY VR, MORRIS J, KNACKSTEDT RW and WARGOVICH MJ: Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon Cancer cells. Anticancer Res 33: 5325-5333, 2013.
15. MUTHUSAMI S, PRABAKARAN DS, AN Z, YU JR and PARK WY: EGCG suppresses Fused Toes Homolog protein through p53 in cervical Cancer cells. Mol Biol Rep 40: 5587-5596, 2013.
16. SINGH T and KATIYAR SK: Green tea polyphenol, (-)-epigallo-catechin-3-gallate, induces toxicity in human skin Cancer cells by targeting β-catenin signaling. Toxicol Appl Pharmacol 273: 418-424, 2013.
17. TAKAHASHI A, WATANABE T, MONDAL A, SUZUKI K, KURUSU-KANNO M, LI Z, YAMAZAKI T, FUJIKI H and SUGANUMA M: Mechanism-based inhibition of Cancer metastasis with (-)-epigallocatechin gallate. Biochem Biophys Res Commun 443: 1-6, 2014.
18. SAKAMOTO Y, TERASHITA N, MURAGUCHI T, FUKUSATO T and KUBOTA S: Effects of epigallocatechin-3-gallate (EGCG) on A549 lung Cancer tumor growth and angiogenesis. Biosci Biotechnol Biochem 77: 1799-1803, 2013.
19. BRAICU C, GHERMAN CD, IRIMIE A and BERINDAN-NEAGOE I: Epigallocatechin-3-Gallate (EGCG) inhibits Cell proliferation and migratory behaviour of triple negative breast Cancer cells. J Nanosci Nanotechnol 13: 632-637, 2013.
20. GUPTA S, HASTAK K, AFAQ F, AHMAD N and MUKHTAR H: Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23: 2507-2522, 2004.
21. GAO Y, LI W, JIA L, LI B, CHEN YC and TU Y: Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarci-noma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways. Biochem Biophys Res Commun 438: 370-374, 2013.
22. LIU S, WANG XJ, LIU Y and CUI YF: PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am J Chin Med 41: 629-642, 2013.
23. COTTER TG: Apoptosis and cancer: The genesis of a research feld. Nat Rev Cancer 9: 501-507, 2009.
24. KUMAR S: Caspase function in programmed Cell death. Cell Death Differ 14: 32-43, 2007.
25. TSUJIMOTO Y: Bcl-2 family of proteins: Life-or-death switch in mitochondria. Biosci Rep 22: 47-58, 2002.
26. Li W, Nie S, Yu Q and Xie M: (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J Agric Food Chem 57: 6685-6691, 2009.
27. Wu PP, Kuo SC, Huang WW, Yang JS, Lai KC, Chen HJ, Lin KL, Chiu YJ, Huang LJ and Chung JG: (-)-Epigallocatechin gallate induced apoptosis in human adrenal Cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. Anticancer Res 29: 1435-1442, 2009.
28. SHEN X, ZHANG Y, FENG Y, ZHANG L, LI J, XIE YA and LUO X: Epigallocatechin-3-gallate inhibits Cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. Int J Oncol 44: 791-796, 2014.
29. RYU DS, KIM SH, KWON JH and LEE DS: Orostachys japonicus induces apoptosis and Cell cycle arrest through the mitochondria-dependent apoptotic pathway in AGS human gastric Cancer cells. Int J Oncol 45: 459-469, 2014.
30. LI J, ZHANG F and WANG S: A polysaccharide from pomegranate peels induces the apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway. Tumour Biol 35: 7475-7482, 2014.
31. BENARBA B, MEDDAH B and AOUES A: Bryonia dioica aqueous extract induces apoptosis through mitochondrial intrinsic pathway in BL41 Burkitt's lymphoma cells. J Ethnopharmacol 141: 510-516, 2012.
32. Hazawa M, Takahashi K, Sugata S and Kashiwakura I: (-)-Epigallocatechin-3-O-gallate induces nonapoptotic Cell death in leukemia cells independent of the 67 kDa laminin receptor. J Nat Prod 74: 695-700, 2011.
33. ISLAM S, ISLAM N, KERMODE T, JOHNSTONE B, MUKHTAR H, MOSKOWITZ RW, GOLDBERG VM, MALEMUD CJ and HAQQI TM: Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 270: 793-797, 2000.
34. TALANIAN RV, QUINLAN C, TRAUTZ S, HACKETT MC, MANKOVICH JA, BANACH D, GHAYUR T, BRADY KD and WONG WW: Substrate speci-fcities of caspase family proteases. J Biol Chem 272: 9677-9682, 1997.
35. LEE YK, BONE ND, STREGE AK, SHANAFELT TD, JELINEK DF and KAY NE: VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104: 788-794, 2004.
36. DEBATIN KM and KRAMMER PH: Death receptors in chemotherapy and cancer. Oncogene 23: 2950-2966, 2004.
37. YU DY, ZHAO QL, FURUTA M, TODORIKI S, IZUMI K, YAMAKAGE K, MATSUMOTO K, NOMURA T and KONDO T: Molecular mechanisms of apoptosis induction by 2-dodecylcyclobutanone, a radiolytic product of palmitic acid, in human lymphoma U937 cells. Apoptosis 17: 636-645, 2012.
38. HAYAKAWA S, SAEKI K, SAZUKA M, SUZUKI Y, SHOJI Y, OHTA T, KAJI K, YUO A and ISEMURA M: Apoptosis induction by epigal-locatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285: 1102-1106, 2001.
39. OLA MS, NAWAZ M and AHSAN H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351: 41-58, 2011.
40. REED JC, JURGENSMEIER JM and MATSUYAMA S: Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 1366: 127-137, 1998.
41. LEE JH, JEONG YJ, LEE SW, KIM D, OH SJ, LIM HS, OH HK, KIM SH, KIM WJ and JUNG JY: EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett 290: 68-75, 2010.
42. IWASAKI R, ITO K, ISHIDA T, HAMANOUE M, ADACHI S, WATANABE T and SATO Y: Catechin, green tea component, causes caspase-independent necrosis-like Cell death in chronic myelogenous leukemia. Cancer Sci 100: 349-356, 2009.
43. DAS A, BANIK NL and RAY SK: Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-Sy5y cells exposed to favonoids. Int J Cancer 119: 2575-2585, 2006.